Articles by Jim Hall - Pharmaceutical Executive


Articles by Jim Hall

Goodbye, Willy Loman

Apr 6, 2009

The days of pharma sales reps going office-to-office with samples and brochures are done. These days, they need to turn their attention to payers, pharmacists, and consumers

A Decade (and 1/2) of Deals

As the industry focuses on late-stage deals, Big Pharma takes on the risks of compounds in preclinical development.
Oct 1, 2004

More than half the deals made by pharma are with companies based in the US, 28 percent in Europe, and 15 percent Japan.


Click here